Acurx PharmaceuticalsACXP
13F holders, Q1 2026 (March 31)21holders +3
5new positions
3sold out
$3.71avg. 13F price*
At the end of Q1 2026, 21 institutions reported holding Acurx Pharmaceuticals Inc. (ACXP) in their 13F filings, up 3 from Q4 2025. 5 opened new positions and 3 sold out. The largest holders were Jane Street Group, LLC ($203K), Vanguard Capital Management LLC ($115K) and Geode Capital Management, LLC ($92K).
- Company
- Acurx Pharmaceuticals Inc.
- CUSIP
- 00510M203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $85K |
| Exits | 3 | $145K |
All 13F filers, Q4 2025 → Q1 2026: 85,533 shares bought and 66,305 shares sold, net +19,228 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Jane Street Group, LLC | 0.00% | Add +408.6% | 54,642 | $203K |
| Vanguard Capital Management LLC | 0.00% | — | 31,099 | $115K |
| Geode Capital Management, LLC | 0.00% | Add +99.9% | 24,819 | $92K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 20,000 | $74K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 16,205 | $60K |
| Prospect Financial Services LLC | 0.03% | Reduce -30.5% | 13,785 | $51K |
| Morgan Stanley | 0.00% | No change | 6,500 | $24K |
| UBS Group AG | 0.00% | Add +3634.9% | 6,312 | $23K |
| Wells Fargo & Company | 0.00% | No change | 2,300 | $9K |
| Westside Investment Management, Inc. | 0.00% | New | 1,650 | $6K |
| Lanark Financial, Inc. | 0.00% | No change | 1,500 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -64.3% | 1,031 | $4K |
| McGuire Capital Advisors Inc. | 0.00% | New | 1,000 | $4K |
| Barclays PLC | 0.00% | New | 380 | $1K |
| Group One Trading LLC | 0.00% | Reduce -13.4% | 245 | $909 |
| Osaic Holdings, Inc. | 0.00% | No change | 100 | $371 |
| Cornerstone Planning Group LLC | 0.00% | No change | 167 | $334 |
| BlackRock, Inc. | 0.00% | No change | 60 | $223 |
| Advisory Services Network, LLC | 0.00% | New | 59 | $219 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -53.9% | 6 | $22 |
| Citigroup Inc. | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is ACXP's weight in each manager's 13F, not the share of Acurx Pharmaceuticals Inc. the manager owns.